This year’s conference brings together fresh perspectives from industry, academic and government researchers and clinicians focused on addressing and solving the significant hurdles remaining in the space.
San Francisco, CA (PRWEB) August 20, 2014
The 6th Annual Arrowhead Personalized and Precision Medicine Conference is being held on October 29-30 in San Francisco, CA. This year’s conference brings together fresh perspectives from industry, academic and government researchers and clinicians focused on addressing and solving the significant hurdles remaining in the space.
In the twelve years since the sequencing of the human genome, more than one hundred therapies have been introduced with pharmacogenetic information in the label and molecular diagnostics have become a part of routine oncology care in some clinics. “But basic, fundamental issues continue to plague the space,” noted Mollie Roth, Managing Partner of PGx Consulting and Chair of the conference, including how to “educate physicians to understand and use this huge volume of genetic data and how to find a business model that works for both the laboratories and diagnostic partners.”
This year’s event, held for the first time on the west coast, will present ground-breaking research and approaches in personalized medicine, including how to generate and deliver clinical genomic sequencing reports for routine clinical use, the impact of Medicare reform on the radically changing market for lab test pricing, educating health care workers on genomics and the reality of the $1,000 genome in clinical practice.
A highlight of this year’s conference will be a three-way conversation on the different perspectives on pricing and reimbursement of lab tests between the government, diagnostic and other industries, moderated by Bruce Quinn, MD, Ph.D., Senior Policy Advisor, Foley Hoag, and featuring:
Louis Jacques, MD, Sr. VP & Chief Clinical Officer, ADVI (formerly the Director, Coverage & Analysis Group at CMS)
Paul Billings, MD, Ph.D., Chief Medical Officer, Omicia (formerly the Chief Medical Officer, Life Technologies, Inc.)
Chris Hall, Chief Commercial Officer, Veracyte
Additional notable speakers include the following experts in the field of Precision Medicine:
Lynn Dowling, El Camino Hospital
W. Andrew Faucett, MS, LGC, Geisinger Health System
Grant Wood, Intermountain Health Care
Glen Weiss, M.D., Cancer Treatment Centers of America
Frank Ong, MD, Illumina
Jonathan Hirsch, Syapse
Vince O’Neill, Exosome Diagnostics
Michael Kolodziej, MD, FACP, Aetna
Jeannette McCarthy, MPH, Ph.D., UCSF Division of Genomic Medicine
The 6th Annual Arrowhead Personalized and Precision Medicine Conference is an opportunity to hear from a unique set of experts and learn what they are doing to overcome the hurdles to full implementation of personalized medicine. Please visit http://www.personalizedmedicinepartnerships.com for the full list of speakers, agenda and registration information.